Neuromodulation Devices Market (By Product Type: Spinal Cord Stimulators, Deep Brain Stimulators; By Technology; By Application; By Biomaterial; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neuromodulation Devices Market 

5.1. COVID-19 Landscape: Neuromodulation Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neuromodulation Devices Market, By Product Type

8.1. Neuromodulation Devices Market, by Product Type, 2022-2030

8.1.1. Spinal Cord Stimulators

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Deep Brain Stimulators

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Sacral Nerve Stimulators

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Vagus Nerve Stimulators

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Transcranial Magnetic Stimulators

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Neuromodulation Devices Market, By Technology

9.1. Neuromodulation Devices Market, by Technology, 2022-2030

9.1.1. Internal

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. External

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Neuromodulation Devices Market, By Application 

10.1. Neuromodulation Devices Market, by Application, 2022-2030

10.1.1. Parkinson’s Disease

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Chronic Pain

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Migraine

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Epilepsy

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Tremor

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Depression

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Urinary & Faecal Incontinence

10.1.7.1. Market Revenue and Forecast (2017-2030)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Neuromodulation Devices Market, By Biomaterial

11.1. Neuromodulation Devices Market, by Biomaterial, 2022-2030

11.1.1. Polymeric Biomaterial

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Metallic Biomaterial

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Ceramic Biomaterial

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Neuromodulation Devices Market, By End-use

12.1. Neuromodulation Devices Market, by End-use, 2022-2030

12.1.1. Hospitals & Ambulatory Surgery Centers (ASC)

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Clinics & Physiotherapy Centers

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Others

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Neuromodulation Devices Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.5. Market Revenue and Forecast, by End-use (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.7. Market Revenue and Forecast, by End-use (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End-use (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Biomaterial (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-use (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Biomaterial (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-use (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.11. Market Revenue and Forecast, by End-use (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.13. Market Revenue and Forecast, by End-use (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.15. Market Revenue and Forecast, by End-use (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.5. Market Revenue and Forecast, by End-use (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.7. Market Revenue and Forecast, by End-use (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.9. Market Revenue and Forecast, by End-use (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-use (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-use (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.5. Market Revenue and Forecast, by End-use (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.7. Market Revenue and Forecast, by End-use (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.9. Market Revenue and Forecast, by End-use (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-use (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-use (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.5. Market Revenue and Forecast, by End-use (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.7. Market Revenue and Forecast, by End-use (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 14. Company Profiles

14.1. Boston Scientific Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Abbott

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. NEVRO CORP.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Neuronetics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Medtronic

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms